Fidaxomicin - Merck
At a glance
- Drug Originator Optimer Pharmaceuticals
- Drug Licenced by Astellas Pharma; AstraZeneca; OBI Pharma; Specialised Therapeutics Australia; Tillotts Pharma
- Drug Class Antibacterials; Glycosides; Macrocyclic compounds; Small molecules
- Mechanism of Action DNA-directed RNA polymerase inhibitors
- USA Patent Applicants CUBIST PHARMS LLC
- USA Patents 15
- NDAs 2
- International Patents 158
- Patent Applications 551
Table of Contents
Disclaimer